Loading...
Dyadic International, Inc.
DYAI•NASDAQ
Healthcare
Biotechnology
$1.10
$-0.02(-1.79%)
Dyadic International, Inc. (DYAI) Financial Performance & Income Statement Overview
Review Dyadic International, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
20.58%
↑ 20.58%
Operating Income Growth
28.30%
↑ 28.30%
Net Income Growth
14.51%
↑ 14.51%
Operating Cash Flow Growth
40.91%
↑ 40.91%
Operating Margin
-162.55%
↓ 162.55%
Gross Margin
66.88%
↑ 66.88%
Net Profit Margin
-163.94%
↓ 163.94%
ROE
-233.69%
↓ 233.69%
ROIC
-97.39%
↓ 97.39%
Dyadic International, Inc. (DYAI) Income Statement & Financial Overview
Review Dyadic International, Inc.'s (DYAI) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $817376.00 | $1.96M | $385896.00 | $334617.00 |
| Cost of Revenue | $352819.00 | $395894.00 | $301956.00 | $143955.00 |
| Gross Profit | $464557.00 | $1.56M | $83940.00 | $190662.00 |
| Gross Profit Ratio | $0.57 | $0.80 | $0.22 | $0.57 |
| R&D Expenses | $545660.00 | $460241.00 | $515629.00 | $522723.00 |
| SG&A Expenses | $1.44M | $1.30M | $1.61M | $1.79M |
| Operating Expenses | $1.99M | $1.76M | $2.12M | $2.31M |
| Total Costs & Expenses | $2.35M | $2.16M | $2.43M | $2.46M |
| Interest Income | $103747.00 | $127331.00 | $138471.00 | $87443.00 |
| Interest Expense | $126233.00 | $128177.00 | $141103.00 | $32458.00 |
| Depreciation & Amortization | $0.00 | $127326.00 | $0.00 | $2.12M |
| EBITDA | -$1.42M | -$75288.00 | -$1.90M | $0.00 |
| EBITDA Ratio | -$1.74 | -$0.04 | -$4.93 | $0.00 |
| Operating Income | -$1.53M | -$202614.00 | -$2.04M | -$2.12M |
| Operating Income Ratio | -$1.87 | -$0.10 | -$5.29 | -$6.34 |
| Other Income/Expenses (Net) | -$20821.00 | -$846.00 | -$2632.00 | $115962.00 |
| Income Before Tax | -$1.55M | -$203460.00 | -$2.05M | -$2.010M |
| Income Before Tax Ratio | -$1.90 | -$0.10 | -$5.30 | -$6.006 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$43277.00 |
| Net Income | -$1.55M | -$203460.00 | -$2.05M | -$2.010M |
| Net Income Ratio | -$1.90 | -$0.10 | -$5.30 | -$6.006 |
| EPS | -$0.05 | -$0.007 | -$0.07 | -$0.07 |
| Diluted EPS | -$0.05 | -$0.007 | -$0.07 | -$0.07 |
| Weighted Avg Shares Outstanding | $29.84M | $29.50M | $29.29M | $28.83M |
| Weighted Avg Shares Outstanding (Diluted) | $29.84M | $29.50M | $29.29M | $28.83M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan